New Key Statistics Module, Z-Score and F-Score
NYSE:CRL Key Ratios
Market Cap $ M | 11,750.85 |
Enterprise Value $ M | 14,502.32 |
P/E(ttm) | 26.77 |
PE Ratio without NRI | 22.04 |
Forward PE Ratio | 20.83 |
Price/Book | 3.23 |
Price/Sales | 2.86 |
Price/Free Cash Flow | 28.41 |
Price/Owner Earnings | 25.39 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4,111.00 |
EPS (TTM) $ | 8.52 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | 15.20 |
5-y EBITDA Growth Rate % | 15.20 |
y-y EBITDA Growth Rate % | -2.70 |
EV-to-EBIT | 21.12 |
EV-to-EBITDA | 14.37 |
PEG | 1.45 |
Shares Outstanding M | 51.51 |
Net Margin (%) | 10.67 |
Operating Margin % | 13.99 |
Pre-tax Margin (%) | 13.36 |
Quick Ratio | 1.37 |
Current Ratio | 1.75 |
ROA % (ttm) | 5.57 |
ROE % (ttm) | 12.98 |
ROIC % (ttm) | 6.49 |
Dividend Yield % | -- |
Altman Z-Score | 2.81 |
CRL Number of Guru Trades
CRL Volume of Guru Trades
Gurus Latest Trades with NYSE:CRL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:CRL is held by these investors
Total 3
Charles River Laboratories International Inc Insider Transactions
No Available Data
News about NYSE:CRL
Total 0- 1